DEVELOPMENT AND OPTIMIZATION OF MANNOSYLATED NARINGENIN LOADED TRANSFERSOMES USING RESPONSE SURFACE METHODOLOGY FOR SKIN CARCINOMA
Objective: The flavonoidal drug Naringenin offers a natural defense against free radical generation due to their antioxidant i.e. free radical scavenging property. The continuation of research work towards the invention of targeting the flavonoidal drug for skin carcinoma. Naringenin is a potent antioxidant, having remarkable reactive oxygen species scavenging potential and abundantly found in citrus fruits.
Methods: The optimization of the formulated mannosylated naringenin-loaded transfersomes (MA-NgTfs) was performed using Box–Behnken statistical design to obtain crucial variable parameters that influence vesicular size, size distribution and surface charge. Therefore keeping both the concepts in mind our objective is to design and optimize the mannosylated naringenin loaded transfersomes (MA-NgTfs) for macropahge targeting. The Box Behnken with 3D surface response design graph was employed to optimize the formulation.
Results: Phospholipids and surfactant ratio played a remarkable role to determine the mean vesicular size and the Zeta potential of the vesicles. The Zeta potential is found in the formulation having a range of-18.01±1.05 to-28.7±1.008 mV represents the good stability of the formulation. The vesicles size range was found in the range of 102.4±1.01 to 263.74±0.63 and range of Entrapment efficiency of nanovesicles was as 72.04±1.53 to 82.04±0.81. In vitro drug release study shows that mannosylated naringenin loaded transfersomes (MA-NgTfs), and marketed formulation dispersion was found 69.31 %, 62.03 %, 58.71 %, and 65.02 % respectively. Ex vivo skin permeation and deposition study shows that the marketed product and pure drug suspension optimized transfersomes through the skin of mice was of flux 6.5±3.07 and the percentage of drug retention was 0.76±1.26. The results gave us strong evidence of cellular uptake bymannose–directed transfersomes via mannose receptor-based endocytosis.
Conclusion: On the basis of findings, the study revealed that the prepared formulation has characteristic potential for targeting and the concept of ligand directed nanocarrier formulation was imparts synergistic effect against UV-induced skin carcinoma.
2. Saraf S, Gupta A, Kaur CD, Jangde M. Dermatological consequences of photosensitization with an approach to treat them naturally. Pak J Biol Sci 2014;17:167-72.
3. Gupta A, Kaur CD, Saraf S, Saraf S. Formulation, characterization and evaluation of ligand-conjugated biodegradable quercetin nanoparticles for active targeting. Artif Cells Nanomed Biotechnol 2016;44:960-70.
4. Tavana O, Benjamin CL, Puebla Osorio N, Sang S, Ullrich SE, Ananthaswamy H, et al. Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence. Cell Cycle 2010;9:3348-56.
5. Chen P, Zhang X, Jia L, Prud'homme RK, Szekely Z, Sinko PJ. Optimal structural design of mannosylated nano carriers for macrophage targeting. J Controlled Release 2014;28:341-9.
6. Gupta A, Kaur CD, Saraf S. Comparative evaluation of two different novel formulations of quercetin against non melanoma skin cancer in human subjects. J Clin Exp Dermatol Res 2016;7:34-9.
7. Martinez RM, Pinho Ribeiro FA, Steffen VS, Silva TC, Caviglione CV, Bottura C, et al. Topical formulation containing naringenin: efficacy against ultraviolet B irradiation-induced skin inflammation and oxidative stress in mice. PloS One 2016;11:e0146296.
8. Pukanud P, Peungvicha P, Sarisuta N. Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer’spatches. Drug Delivery 2009;16:289-94.
9. Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomed Nanotech Biol Med 2012;8:237-49.
10. Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into the skin. Int J Pharma 2003;258:141-51.
11. Tsai MJ, Huang YB, Fang JW, Fu YS, Wu PC. Preparation and characterization of naringenin-loaded elastic liposomes for topical application. PloS One 2015;10:1013-26.
12. Yang S, Liu C, Liu W, Yu H, Zheng H, Zhou W, et al. Preparation and characterization of nanoliposomes entrapping medium-chain fatty acids and vitamin C by lyophilisation. Int J Mol Sci 2013;14:19763-73.
13. Jangdey MS, Kaur CD, Saraf S. Efficacy of concanavalin-a conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma. Art Cel Nanomed Biotech 2019;47:904-16.
14. Shinde G, Patel M, Mehta M, Kesarla R, Bangale G. Formulation, optimization, and characterization of repaglinide loaded nanocrystal for diabetes therapy. Adv Pharma 2015. https://doi.org/10.1155/2015/363061
15. Sayyad MK, Zaky AA, Samy AM. Fabrication and characterization of sildenafil citrate loaded transfersomes as a carrier for transdermal drug delivery. Pharm Pharmacol Int J 2017;5:100-13.
16. Sumathi R, Tamizharasi S, Sivakumar T. Formulation and evaluation of polymeric nanosuspension of naringenin. Int J Appl Pharm 2017;9:60 70.
17. Jangdey MS, Gupta A, Saraf S, Saraf S. Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation. Artif Cells Nanomed Biotechnol 2017;45:1452-62.
18. Chaubey P, Patel RR, Mishra B. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. Exp Opin Drug Delivery 2014;1:1163-81.
19. Qushawy M, Nasr A, Abd-Alhaseeb M, Swidan S. Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutice 2018;10:26-32.
20. Upasana Y, Nuzhat H, Qamar R. Formulation of nanoparticles of E prosartan mesylate for better drug delivery by improving solubility. Asian J Pharm Clin Res 2018;11:260-3.
This work is licensed under a Creative Commons Attribution 4.0 International License.